Yet another new mRNA vaccine for COVID? Really?
Public participation in the latest versions of the COVID boosters has been inarguably abysmal. (As of last month, less than 4% of adult Americans had received one of the updated boosters, according to NBC News.) But that doesn’t seem to be slowing down the pharmaceutical industry or dampening its appetite for even more experimentation. Inside […]